
FDAã¯SV40ãå«ããäžèäžæ»ã®åŠè¬ãã®èšåºè©Šéšãæ¿èªããŸããïŒ
ãããç§ãäœãäžããŠããã°ããã£ãã®ã§ãããç§ã¯ãããŸã§åµé çã§ã¯ãããŸããã
Sasha LatypovaãFeb 07, 2026
ã¯ãããã现èã¯æè¡çã«ã¯äžæ»ã§ãããŸãããã®äžèœè¬ããå¹ããããã«ã¯ãæçç©è³ªãšã¹ããã€ãã®ç¶ç¶çãªæäžãç¡æéã«ç¶ããå¿ èŠããããŸã
1 æ 27 æ¥ããã¹ã³ãã¯äžèäžæ»ãæ±ãã人ã ã«ãšã£ãŠçŽ æŽããããã¥ãŒã¹ãäŒããããé·å¯¿åéã®äž»èŠãªãã¹ãã§ãFDA ã现èã®ãã»ãŒå®å šãªãªã»ãããã«é¢ããç ç©¶ãæ¿èªãã
ããŒããŒã倧åŠã®çç©åŠè ããããã»ã·ã³ã¯ã¬ã¢æ°ãå ±åèšç«ãããã€ãªãã¯ãããžãŒã®æ°èäŒæ¥ã©ã€ãã»ãã€ãªãµã€ãšã³ã¹ã¯ãæ»ã«ãã现èã®å¯¿åœãå»¶ã°ãããã«èšèšãããéºäŒåæ²»çã®èšåºç ç©¶ãéå§ããèš±å¯ãFDAããåŸãã
ã©ã€ããã€ãªç€Ÿã¯ããã®ã¢ãããŒãããéšåçãšããžã§ããã£ãã¯ã»ãªããã°ã©ãã³ã°ããšåä»ããŠãããä»åã®èšåºè©Šéšã¯ããã§ãã®æŠå¿µãæ€èšŒããåã®è©Šã¿ãšãªããããã¯ã现èè¥è¿ããšããŠç¥ãããå®éšçæ²»çæ³ãšããããåºç¯ãªé åã«å±ããããã¯äŒæ¥ã®å¹¹éšããæ¯æŽããè³éåã®ããè€æ°ã®ã¹ã¿ãŒãã¢ããäŒæ¥ã泚åããŠããã
ããŠãæ©éããã€ãã®ããã«æå³ã®ãªãäœã話ã®å°éçšèªãåºãŠããŸãããšããžã§ããã£ã¯ã¹ïŒã²ãã ã®97%ãäœã®ã³ãŒããçæã§ããªããšããç¶æ³ãæãããã®ãããã°ç©èªçãªææžçïŒãšãæå®³ãªéºäŒåæ²»çãã现èã®è¥è¿ãããšåŒã¶ããšããã¡ãããããããããšã§ãããâŠ
ã©ã€ããã€ãªã¯ãæ¥æé·äžã®ã现èè¥è¿ããåéã«åŸçºã§åå ¥ããã4幎åã«èšé²çãª30åãã«ã調éããŠèšç«ãããç§å¯äž»çŸ©ã®ã¹ã¿ãŒãã¢ããäŒæ¥ãã¢ã«ãã¹ã»ã©ãã¯ãæè³å®¶ã«ã¢ããŸã³ã®ãžã§ãã»ããŸã¹æ°ãåãé£ããŠãããšå ±ããããŠãããå瀟ã¯ç¬èªã®éšåçãšããžã§ããã£ãã¯ã»ãªããã°ã©ãã³ã°æè¡ã®éçºã«åãçµãã§ãããã¢ã«ãã¹ã»ã©ãã¯æ°ååãã«ã®è³éã調éãã倧åŠã®ååŠéšããã¹ã¿ãŒç ç©¶è ãåããèåãé ãããããå·»ãæ»ãããããæ²»çæ³ã®éçºãç®æããŠããããããããã®è³éãšäººæãäœã«äœ¿ã£ãŠããã®ãã«ã€ããŠã¯ãã»ãšãã©æããã«ããŠããªãã
æšå¹Žã¹ãã€ã³ã§éå¬ãããå»çäŒè°ã§ããã®ã¹ã¿ãŒãã¢ããäŒæ¥ã®åµæ¥è ã§ãããã¢ã³ã»ã«ã«ãã¹ã»ã€ãºãã¹ã¢ã»ãã«ã¢ã³ãæ°ã¯ãå瀟ãèåã«ã€ããŠã©ã®ããã«èããã©ã®ããã«ãããé£ãæ¢ããããšããŠããã®ããå£éèŠãããã©ããããã¢ã«ãã¹ã¯ãéšåçãªãªããã°ã©ãã³ã°ãçæ³ã«åãçµãã§ãããäœããæåºãããèåšãçåœç¶ææ¶²ãèåšã«æ³šå ¥ããè£ çœ®ã§çããããã®å®éšçãªãªããã°ã©ãã³ã°çæ³ã詊éšããŠããããã ã
èªè ã®çãããããã¯ãŸããšããŸããèåšæäŸè ãªã¹ããžã®ç»é²ããããŠå¯èœã§ããã°å»çé»åèšé²ã®å ±æã«ãå¿ ããªããã¢ãŠãããŠãã ããããµã€ã³ãã¹ããšãªãŒãããã¡ã¯æè¿ããèåšæäŸãã«ã€ããŠéåžžã«åŒ·åŒã§ããéæ³ãªèåšå£²è²·ã暪è¡ããŠããŸãã
äžæ»è©æ¬ºã®æ¬¡ç¹ã®ãã1瀟ã¯ãOpenAIã®ãµã ã»ã¢ã«ããã³æ°ãæ¯æŽããã¹ã¿ãŒãã¢ããäŒæ¥Retro Biosciencesã ããŸããCoinbaseã®CEOãã©ã€ã¢ã³ã»ã¢ãŒã ã¹ããã³ã°æ°ãæ¯æŽããNewLimitã现èåããã°ã©ãã³ã°çæ³ã«åãçµãã§ããã
è©±ãæ¬é¡ã«æ»ããŸãããããã¹ãã³ã«æ ç¹ã眮ãåŸæ¥å¡20åæªæºã®ã¹ã¿ãŒãã¢ããäŒæ¥Life Bioããä»ç€Ÿã«å é§ããŠ[#MAHA!]-FDAïŒç±³åœé£åå»è¬åå±ïŒã®æ¿èªãååŸããçããããã察象ãšããèšåºããã°ã©ã ãéå§ããŸãããFDAã¯ãé©ãã¹ãããšã«ãèåãã®ãã®ãçŸæ£ãšããŠèªããŠããŸããããã®ãããå瀟ã®ç¬¬1çžèšåºè©Šéšã§ã¯ãç·å éãšãããçšãªçŸæ£ã§ããéåèçæ§åéšèè¡æ§èŠç¥çµçïŒNAIONïŒãšãã2çš®é¡ã®èŠååªå€±åœ¢æ ã察象ã«ãéºäŒåæ²»çã詊éšããŸããå瀟ã®ãã¬ã¹ãªãªãŒã¹ããã³ãã¥ãŒã¹èšäºããã®åŒçšã§ãã
ãµã«ãçšããã¬ãŒã¶ãŒèªå°NAIONã¢ãã«ã«ãããŠãER-100ãšåä»ãããããã®æ²»çæ³ã¯ãæå·ãããšãã²ãã ã修埩ããèŠç¥çµã®é»æ°ä¿¡å·ãæ¹åãããã©ã€ããã€ãªç€Ÿã®æé«ç§åŠè²¬ä»»è ã§ããã·ã£ãã³ã»ããŒãŒã³ãã¯ã€ã°ïŒãªããœã³æ°ã¯ããã®çµæã¯ãã®æ²»çæ³ãæå·ãã现èã®å¥åº·ç¶æ ãæ¹åã§ããããšã瀺ããŠãããšè¿°ã¹ããããã§ã«æ»æ» ãã现èã眮ãæãããã®ã§ã¯ãªããšè¿°ã¹ãã
äžæè°ãªããšã«ããã®ç§åŠçã®å€§ãããäœã¯æ»èªãåããŠããŸããïŒChatGPTã«ãããšãER-100çæ³ãçšãã ç¹å®ã®éããéé·é¡ïŒãµã«ïŒNAIONç ç©¶ã«é¢ããæ»èªæžã¿ã®ç§åŠèªãžã®æ²èŒã¯çŸæç¹ã§ã¯èŠã€ãã£ãŠããªããšã®ããšã§ããã€ãŸããã·ã£ãã³ã»ããŒãŒã³ãã¯ã€ã°ïŒãªããœã³æ°ãšãã®éçšäž»ã¯ã声æãæé ããŠããå¯èœæ§ã¯ãããŸããã誰ããããæ€èšŒããããšãã§ããªãã®ã§ãã
Life Bio ã¯æèšãæ»ãã¡ã«ããºã ã«ã€ããŠã©ã®ãããªããšã䞻匵ããŠããã®ã§ãããã?
æ°å¹Žåãæ¥æ¬ã®ç§åŠè å±±äžäŒžåŒ¥æ°ã¯ã4ã€ã®ã¿ã³ãã¯è³ªãæäœçްèã幹现èãžãšå€åãããããšãçºèŠããŸãããããã¯ããŒãã«è³ãåè³ããå®éšã§ããããšããžã§ããã£ãã¯ãªãªã»ãããå¯èœã§ããããšã蚌æããŸããããããããŒãã«è³åè³ã§ãïŒãããããå±±äžå åããšåŒã°ãããã®4ã€ã®ã¿ã³ãã¯è³ªãåç©ãããã«çŽæ¥å°å ¥ããããšã¯ãé·ããæªãèããšèããããŠããŸããããã®çç±ã®äžã€ã¯ããã®ã¿ã³ãã¯è³ªã®äžã€ãããä¿é²ã¿ã³ãã¯è³ªc-Mycã§ããããã§ãã
ãã£ãšãããããã现èã®äžæ»åã£ãŠãã®ããããã ããçãã£ãŠèšããã ã
ãä»ã®ç 究宀ã§ã¯4ã€ãã¹ãŠãæäžããããŠã¹ãæ»ãªãããè «çãåŒãèµ·ããããããããšãçºèŠããããšã·ã³ã¯ã¬ã¢æ°ã¯èªã£ãã
ã«ãŒãšã·ã³ã¯ã¬ã¢ã¯ã²ããããšãªããã·ã³ãã«ãªãããèŠéããããã¡ãªå®éšãæãã€ããŸãããããã¯ãå±±äžå åã®æ®ã3ã€ã䜿ããšãããã®ã§ãããããã¯ãŸãã«å€©æçãªã¢ã€ãã¢ã§ãããŸããâŠããå åã§ã¯ãªããä»ã®3ã€ã䜿ããªããŠïŒãããã®ã¿ã³ãã¯è³ªãOct4ãSOX2ãKLF4ãç¥ããŠOSKã¯ããè¥ã ãããšããžã§ããã£ãã¯ã³ãŒããå埩ãããç·å éã®ããŠã¹ã¢ãã«ã«ãããèŠåäœäžãå埩ããããããšã«æåããŸããã
ãããããã®äžèŠå¥è·¡çãªç ç©¶ãããå°ã詳ãã調ã¹ãŠã¿ããããã®ç ç©¶ã¯2020幎ã«ãã€ãã£ãŒèªã®è¡šçŽã食ãããšããžã§ããã£ãã¯ã»ãªããã°ã©ãã³ã°ãžã®é¢å¿ãåŒã³èµ·ãããã©ã€ããã€ãªç€Ÿã®éºäŒåæ²»çã®åºç€ãšãªã£ããè«æã¯è³Œå ¥ã®ã¿å¯èœã§ãç§ã¯è³Œå ¥ãããåªæãæå®³ãªç ã§æºã¡ãæ¬æãã¹ã¯ããŒã«ããåèæç®ãéãéããŠã7ããŒãžã®ãæ¹æ³ãã»ã¯ã·ã§ã³ãèŠã€ããªããã°ãªããªããèªè ã®çãããç§ã¯ãæ¹æ³ããæ»èªä»ãè«æã®åé ãéåžžã¯åºè«ã®çŽåŸã«å¿ é ã®ã»ã¯ã·ã§ã³ã ã£ãæä»£ãèŠããŠããã»ã©æ³ããšã£ãŠãããç§åŠè©æ¬ºã暪è¡ããæšä»ããã®ã»ã¯ã·ã§ã³ã¯ã誰ããããŸã§èªãæéããªãããšãæåŸ ããŠãåŸãã®ã»ããä»é²ã«é ãããŠããã®ãéäŸã ãããã¯ç§ãè«æã§æ¢ããŠèªãæåã®ã»ã¯ã·ã§ã³ã ããããŠããªããšããããæåŸ éãã®çµæããããããã®ã ïŒã©ã€ããã€ãªããžãã¯ãžã¥ãŒã¹ã¯âŠãã©ã ããŒã«âŠååŠãŽããšããç¥ãããçãåŒãèµ·ããSV40ãããã¢ãŒã¿ãŒãã§ãã£ã±ãã®ã¢ãããŠã€ã«ã¹ã§ãã

AAV-TRE-OSKãã¯ã¿ãŒã¯ãããŠã¹Oct4ãSox2ãããã³Klf4 cDNAããããã©ãµã€ã¯ãªã³å¿çé åïŒTRE3GïŒããã¢ãŒã¿ãŒãšSV40é åãããªãAAVãã©ã¹ããã«ã¯ããŒãã³ã°ããããšã«ãã£ãŠäœè£œãããŸããããã®ä»ã®èªå®¶è£œãã¯ã¿ãŒã¯ãåæ§ã®æŠç¥ãçšããŠäœè£œããããçŽæ¥ååŠåæããŸããããã¹ãŠã®pAAVïŒè£è¶³è¡š4ïŒã¯ãè¡æž å2/2ã2/DJããŸãã¯2/9ã®AAVïŒå䟡ïŒ>5Ã1012ã²ãã ã³ããŒ/mlïŒã«ããã±ãŒãžã³ã°ãããŸãããAAVã¯ãã¹ãã³å°å ç é¢ãŠã€ã«ã¹ã³ã¢ã«ãã£ãŠè£œé ãããŸãã
ããã§ããSV40 ã¯ãããç¥ãããçºããæ§ååŠç©è³ªã§ãæ§ã ãªåç©ã¢ãã«ã«ãããŠæ§ã ãªçš®é¡ã®ãããšé¢é£ä»ããããŠãããããã®ãããšã®é¢é£æ§ãææèªããããŠããŸãããã¡ã€ã¶ãŒç€Ÿã®mRNAãžã¥ãŒã¹ãã¯ãããšããå€ãã®ãéºäŒåç·šéãã«ã¯ãã«ã«ç¢ºå®ã«å«ãŸããŠããŸããå§å©ãèãããé²ãããã«èšã£ãŠãããŸãããéºäŒåæ²»çã«çšããããSV40ã¯åæååŠç©è³ªã§ãããœãŒã¯ã»ã»ãŒãã³ã®ããªãªã¯ã¯ãã³æ¥çš®åŸã«ããã®æµè¡ãåŒãèµ·ããããšããããµã«ã®ãŠã€ã«ã¹ãæ±æãã«ç±æ¥ãããšäž»åŒµãããŸããããçŸåšã§ã¯SV40ãçã£ãŠãµã«ãç©ãããããšã¯ãããŸãããå®éã仿¥ã®ã¯ã¯ãã³è£œé ã«ãããæªéçãªååŒã§å žåçã«äœ¿çšããããµã«ã®è è现èã¯ãSV40ã®æ€æ»ãåããŠããŸãïŒããããã©ã®æ€çŽ¢ãšã³ãžã³ãããããçãåŒãèµ·ããããã§ã¯ãªãããã âŠãªããªãâŠç§ãã¡ã¯ãã çç±ããªãæ€æ»ããŠããã ãâŠãéãç¡äœçºã«äœ¿ãããããã§ãâŠé»ã£ãŠïŒïŒãããããSV40ãŸãã¯ãã®æåãæå³çã«åæããéºäŒåæ²»çã®äž»èŠæåãšããŠå«ããããšã¯å šãåé¡ãããŸããïŒã©ã€ããã€ãªã®å€©æãã¡ã¯ã4ã€ã®ãå±±äžå åãïŒãããã®ååŠç©è³ªãäœã§ããïŒã®çç©è³ªã®1ã€ã§ããc-Mycããå¥ã®ç©è³ªã§ããSV40ã«çœ®ãæããŸããã
Nature èªã®è«æã®æ®ãã®éšåã¯ãããŠã¹ã®ç·å éãæ²»çããèŠåãæ¹åãããšäž»åŒµããŠããŸãããã®éãã§ããç·å éã®ãã¢ãã«ãã¯ãããŠã¹ã®çŒã«ãã€ã¯ãããŒãºãæ³šå ¥ããŠçŒå§ãäžæããããç·å éããšåŒã¶ãšãããã®ã§ãããã¡ãªã¿ã«ãããã¯çŒã®å€å·ã§ãããç·å éãã®ãã®ã代衚ãããã®ã§ã¯ãããŸãããããŠã¹ã®äžã«ã¯å埩ãããã®ãããŸããèŠåã®æ¹åã«ã€ããŠã¯ãã©ã®ããã«å€å®ãããã®ãç§ã«ã¯çè§£ã§ããŸãããããŠã¹ã«èŠåæ€æ»è¡šãèªãŸããã®ã§ããããïŒç§ã¯èŠèŠç§åŠã®åç©ã¢ãã«ã«ç²ŸéããŠããŸãããããŠã¹ã¯ä¿¡é Œæ§ã®é«ãèŠåæ€æ»ã«ã¯é©ããŠããŸããã
çµè«ãšããŠããã®äžèäžæ»ã®åŠè¬ã¯é éšå€å·ã«ããç·å éãæ²»ããããããªãããæ°åã³ããã¯ã¯ãã³ã®å€§æšäºã§èŠãŠããããã«ãéåžžã«é«ã確çã§çãåŒãèµ·ããããšã«ãªãã ããã
MAHA-FDAã¯ãSV40ãå«ãéºäŒåã«ã¯ãã«ã泚å°ããã人ã«äœãèµ·ããããååã«ææ¡ããŠããã«ãããããããã©ã€ããã€ãªã®ããç ç©¶ãæ¿èªããŸããã宣äŒãããŠããç ç©¶èšç»ã§ã¯ãèšåºè©Šéšã§ã¯1ã€ã®ãŠã€ã«ã¹ãã¯ã¿ãŒïŒã¢ãããŠã€ã«ã¹ãã¢ã¹ãã©ãŒãã«ã®æ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³ã«äœ¿çšããããã®ãšåããã©ãããã©ãŒã ïŒã䜿çšããŠã3ã€ã®å±±äžã¿ã³ãã¯è³ªïŒ4ã€ç®ã®SV40ã«ã€ããŠã¯èšåããŠããŸããïŒãç¶²èç¥çµç¯çްèã«ééãããšãããŠããŸããããããã¡ãã£ãšåŸ ã£ãŠãã ããïŒãã®è£ 眮ã«ã¯ãå®å šã¹ã€ããããå«ãŸããŠããŸãã
2ã€ç®ã®ãŠã€ã«ã¹ãã¯ã¿ãŒã¯ãæçç©è³ªããã·ãµã€ã¯ãªã³ã«ãã£ãп޻æ§åãããå®å šã¹ã€ãããšããŠæ©èœããã¿ã³ãã¯è³ªãã³ãŒãããŠããŸããæ£è ãé å€ãæçšãããšéºäŒåæ²»çããªã³ã«ãªããæçšãäžæ¢ãããšéºäŒåæ²»çã¯ãªãã«ãªããŸãã
å瀟ã®ä»åŸã®ç ç©¶ã§ã¯ãæ£è ã¯ããã·ãµã€ã¯ãªã³ã8é±éæçšããäžéšã®éºäŒåæ²»çã§ã¿ãããççã®ãªã¹ã¯ã軜æžããããã«ã¹ããã€ãã䜵çšããŸããå瀟ã¯ãæå€§6人ã®ç·å 鿣è ã察象ã«2çš®é¡ã®ç°ãªãçšéã§è©Šéšãè¡ããæçµçã«æå€§6人ã®NAIONæ£è ã察象ã«è©Šéšããçšéãæ±ºå®ããäºå®ã§ãã
ãããããããšã«ããã®ç ç©¶ã¯12人ã®äžéãªè¢«éšè ã®ã¿ã察象ãšããå®éšã§ãããããããã®æ°žé ã®è¥ããšããå¥è·¡ãã©ã®ããã«æ©èœããã®ããç§ã«ã¯å šãçè§£ã§ããŸããããã æŽ»æ§åãããããã ãã«8é±éãæçç©è³ªãšã¹ããã€ããæçšããã®ã§ããããïŒé·æçãªãè¥è¿ããã¯ã©ããªã®ã§ããããïŒè¥ããä¿ã€ããã«ããã·ãµã€ã¯ãªã³ãšã¹ããã€ããäžçæçšããå¿ èŠãããã®ã§ããããïŒæãçµãŠã°åããã§ãããã